Dr Reddys Lab launches hypertension drug in US
Pharma major Dr Reddys Laboratories today said it has begun the sale of Amlodipine Benazepril capsules, used for the treatment of hypertension, in the US.
The company launched the Amlodipine Benazepril capsules, which are a bio-equivalent generic version of Lotrel capsules, in the US market on April 23, Dr Reddys Laboratories said in a filing to the Bombay Stock Exchange (BSE).
The United States Food & Drug Administration granted approval for the Amlodipine Benazepril capsules on April 15, it said.
"In September 2009, Dr Reddys Laboratories had entered into a patent settlement with Novartis on Amlodipine Benazepril, stipulating the dismissal of the lawsuits in the US," it added.
Shares of Dr Reddys Lab were trading at Rs 1,234.05 on the BSE, up 1.71 per cent from the previous close.